Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

847 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Kobayashi M, Numakura K, Hatakeyama S, Ishida T, Koizumi A, Tadachi K, Igarashi R, Takayama K, Muto Y, Sekine Y, Sobu R, Sasagawa H, Akashi H, Kashima S, Yamamoto R, Nara T, Saito M, Narita S, Ohyama C, Habuchi T. Kobayashi M, et al. Among authors: koizumi a. Int J Clin Oncol. 2023 Nov;28(11):1530-1537. doi: 10.1007/s10147-023-02394-y. Epub 2023 Aug 8. Int J Clin Oncol. 2023. PMID: 37552353
BRCA2 Frameshift Mutation in de novo Small-Cell Neuroendocrine Carcinoma of the Prostate: A Case Report.
Okubo K, Narita S, Koizumi A, Takahashi Y, Sagehashi R, Mori K, Sobu R, Sato H, Kashima S, Kobayashi M, Yamamoto R, Nara T, Numakura K, Saito M, Nanjo H, Habuchi T. Okubo K, et al. Among authors: koizumi a. Case Rep Oncol. 2023 Aug 14;16(1):621-627. doi: 10.1159/000531134. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37900835 Free PMC article.
Research team diversity impacts scientific output in allergy and immunology programs.
Adachi T, Narimatsu N, Ogawa Y, Toriya M, Fukushi T, Shirabe M, Futamura M, Inomata T, Kainuma K, Kan-O K, Kurashima Y, Masaki K, Nakajima S, Sakashita M, Sato S, Tamari M, Morita H, Koizumi A. Adachi T, et al. Among authors: koizumi a. World Allergy Organ J. 2024 Dec 12;18(1):101004. doi: 10.1016/j.waojou.2024.101004. eCollection 2025 Jan. World Allergy Organ J. 2024. PMID: 39758937 Free PMC article.
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity.
Matsuda T, Kaji K, Nishimura N, Asada S, Koizumi A, Tanaka M, Yorioka N, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Akahane T, Yoshiji H. Matsuda T, et al. Among authors: koizumi a. Heliyon. 2024 Sep 27;10(19):e38647. doi: 10.1016/j.heliyon.2024.e38647. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39398008 Free PMC article.
847 results